Identification of gene polymorphisms of human DNA topoisomerase I in the National Cancer Institute panel of human tumour cell lines
Open Access
- 19 September 2006
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 95 (7) , 906-913
- https://doi.org/10.1038/sj.bjc.6603361
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Predicting drug response and toxicity based on gene polymorphismsCritical Reviews in Oncology/Hematology, 2005
- Predicting drug response based on gene expressionCritical Reviews in Oncology/Hematology, 2004
- Predicting drug response based on gene expressionCritical Reviews in Oncology/Hematology, 2004
- Molecular Determinants of the Cytotoxicity of Platinum CompoundsCancer Research, 2004
- Active Site Mutations in DNA Topoisomerase I Distinguish the Cytotoxic Activities of Camptothecin and the Indolocarbazole, RebeccamycinPublished by Elsevier ,2002
- A gene expression database for the molecular pharmacology of cancerNature Genetics, 2000
- Gene Mutation Analysis and Quantitation of DNA Topoisomerase I in Previously Untreated Non‐small Cell Lung CarcinomasJapanese Journal of Cancer Research, 1997
- No Alteration in DNA Topoisomerase I Gene Related to CPT‐11 Resistance in Human Lung CancerJapanese Journal of Cancer Research, 1996
- Appendix I: An Introduction to DNA Supercoiling and DNA Topoisomerase-Catolyzed Linking Number Changes of Supercoiled DNAPublished by Elsevier ,1994
- Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell LinesJNCI Journal of the National Cancer Institute, 1991